COMMUNIQUÉS West-GlobeNewswire

Avid Bioservices To Report Financial Results For Third Quarter Of Fiscal Year 2019 After Market Close On March 11, 2019

04/03/2019 - 14:05

TUSTIN, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

MyoKardia Announces Positive Six-Month Safety and Efficacy Data from PIONEER-OLE Study of Mavacamten for the Treatment of Symptomatic, Obstructive HCM

04/03/2019 - 14:02

Mavacamten Well Tolerated; Results Show Statistically Significant Elimination of Obstruction and Durable NYHA Class Improvements Statistically Significant Improvement in Several Key Biomarkers Suggest Potential for [...]

EDAP TMS SA : HIFU Pioneer Houston Methodist Hospital Acquires EDAP's Next Generation Focal One HIFU System

04/03/2019 - 14:01

Houston Methodist's Upgrade from Ablatherm to Focal One Reinforces EDAP's Position as a Leading HIFU Innovator LYON, France, March 4, 2019 -- EDAP TMS SA (Nasdaq: EDAP) -- Houston Methodist Hospital, one of the first [...]

Saint Anthony Hospital expands Allscripts partnership to enable clinical data integration between ambulatory and acute settings

04/03/2019 - 14:01

Hospital extends and further expands portfolio to provide single clinical and financial record CHICAGO, March 04, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) announced today that Saint Anthony Hospital has signed [...]

RedHill Biopharma Announces New European and Japanese Patents for Talicia®

04/03/2019 - 14:00

The European and Japanese patent applications have been accepted and, once granted, are expected to be valid until 2034 U.S. NDA for Talicia ® on track for potential submission in H1/2019 and U.S. commercial launch in [...]

Ovid Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11

04/03/2019 - 14:00

NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Misonix Names Sharon Klugewicz Chief Operating Officer

04/03/2019 - 14:00

Proven C-Suite Executive Brings Extensive Healthcare Industry Experience to New Role FARMINGDALE, N.Y., March 04, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of [...]

Rexahn Announces Target Enrollment Reached in Phase 2a Clinical Trial of RX-3117 in Combination With ABRAXANE® in First-line Metastatic Pancreatic Cancer Patients

04/03/2019 - 14:00

Expected Study Completion in Second Half 2019 ROCKVILLE, Md., March 04, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative [...]

The Joint Corp. to Present at the 31st Annual ROTH Conference

04/03/2019 - 14:00

To offer free chiropractic adjustments March 17 through March 19 SCOTTSDALE, Ariz., March 04, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics [...]

Neon Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference

04/03/2019 - 14:00

CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that Hugh O’Dowd, Chief [...]

Immunomedics to Participate in Cowen and Company 39th Annual Health Care Conference

04/03/2019 - 14:00

MORRIS PLAINS, N.J., March 04, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Chimerix to Present at Cowen and Company 39th Annual Health Care Conference

04/03/2019 - 14:00

DURHAM, N.C., March 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that Timothy Trost, Chief [...]

Jounce Therapeutics to Present at Cowen and Company 39th Annual Health Care Conference

04/03/2019 - 14:00

CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

Immutep to Present at Oppenheimer’s 29th Annual Healthcare Conference

04/03/2019 - 14:00

SYDNEY, Australia, March 04, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

AnaptysBio to Present at the Cowen and Company 39th Annual Health Care Conference

04/03/2019 - 12:30

SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]

Tetra Bio-Pharma and Santé Cannabis Announce Completion of the First Phase 2 Cannabis Oil Trial in Cancer and Non-Cancer Patients

04/03/2019 - 12:30

OTTAWA, March 04, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-derived drug development and discovery, is pleased to announce [...]

Autolus Therapeutics to Present New Data on AUTO1 at the American Association of Cancer Research (AACR) Annual Meeting 2019

04/03/2019 - 12:30

LONDON, March 04, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a late-breaking [...]

Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency

04/03/2019 - 12:30

- TransCon hGH demonstrated comparable safety and tolerability to a daily hGH - - Potential once-weekly treatment option to overcome long-standing challenges with administration of daily hGH - - Currently no available [...]

Orion Corporation: Managers' transactions - Virve Laitinen

04/03/2019 - 11:24

ORION CORPORATION MANAGERS' TRANSACTIONS 4 March 2019 at 11.45 EET Orion Corporation: Managers' transactions - Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]